Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A


Cirak Y. , Varol U., Atmaca H., Kisim A., Sezgin C., KARABULUT B., ...Daha Fazla

BJU INTERNATIONAL, cilt.110, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

OBJECTIVES